Showing results (411-420 of 666) with videos related to
Sort By:
Pageof 67
Journal of Surgical Oncology|July 1, 1994
Loss of alpha 1 beta 1 and reduced expression of other beta 1 integrins and CAM in lung adenocarcinoma compared with pneumocytesE Roussel, M C Gingras, J Y Ro, et al.Journal of Virological Methods|September 1, 1993
In vitro detection of bovine immunodeficiency-like virus using monoclonal antibodies generated to a recombinant gag fusion proteinY Wannemuehler, J Isaacson, M Wannemuehler, et al.Cancer Research|June 15, 1990
Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alphaS C Yang, L B Owen-Schaub, J A Roth, et al.Human Gene Therapy|August 1, 1993
Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotypeY Zhang, T Mukhopadhyay, L A Donehower, et al.Cytokine|November 1, 1992
IL-1 synergy with IL-2 in the generation of lymphokine activated killer cells is mediated by TNF-alpha and beta (lymphotoxin)A W Lazenby, J A Roth, L B Owen-Schaub, et al.Gene Therapy|September 7, 2002
Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell lineL Zhang, J Gu, T Lin, et al.Radiology|January 1, 1992
Pulmonary metastases: MR imaging with surgical correlation--a prospective studyI M Feuerstein, D L Jicha, H I Pass, et al.Annals of Surgical Oncology|January 1, 1994
Intrapleural photodynamic therapy: results of a phase I trialH I Pass, T F DeLaney, Z Tochner, et al.Oncogene|August 1, 2017
Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesotheliomaA Szymiczek, M Carbone, S Pastorino, et al.Cancer|June 15, 1996
Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinomaB K Temeck, J E Liebmann, C Theodossiou, et al.Pageof 67